Global Medication Management in Oncology Supply, Demand and Key Producers, 2023-2029

Global Medication Management in Oncology Supply, Demand and Key Producers, 2023-2029

Page: 95

Published Date: 23 Mar 2023

Category: Medical Care

PDF Download

Get FREE Sample

Customize Request

  • sp_icon1 sp_icon1_b Description
  • sp_icon2 sp_icon2_b Table of Contents
  • sp_icon3 sp_icon3_b Table of Figures
  • sp_icon4 sp_icon4_b Research Methodology
  • sp_icon1 sp_icon1_b Related Reports
  • sp_icon1 sp_icon1_b Product Tags
btl

Description

The global Medication Management in Oncology market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).

This report studies the global Medication Management in Oncology demand, key companies, and key regions.

This report is a detailed and comprehensive analysis of the world market for Medication Management in Oncology, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Medication Management in Oncology that contribute to its increasing demand across many markets.

Highlights and key features of the study
Global Medication Management in Oncology total market, 2018-2029, (USD Million)
Global Medication Management in Oncology total market by region & country, CAGR, 2018-2029, (USD Million)
U.S. VS China: Medication Management in Oncology total market, key domestic companies and share, (USD Million)
Global Medication Management in Oncology revenue by player and market share 2018-2023, (USD Million)
Global Medication Management in Oncology total market by Type, CAGR, 2018-2029, (USD Million)
Global Medication Management in Oncology total market by Application, CAGR, 2018-2029, (USD Million)
This reports profiles major players in the global Medication Management in Oncology market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include B. Braun Melsungen AG, Dana-Farber Cancer Institute, MedicoRx, McKesson Corporation and Kroger Specialty Pharmacy, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Medication Management in Oncology market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.

Global Medication Management in Oncology Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World

Global Medication Management in Oncology Market, Segmentation by Type
Oral
Injection
Smear

Global Medication Management in Oncology Market, Segmentation by Application
Hospital
Clinic
Others

Companies Profiled:
B. Braun Melsungen AG
Dana-Farber Cancer Institute
MedicoRx
McKesson Corporation
Kroger Specialty Pharmacy

Key Questions Answered
1. How big is the global Medication Management in Oncology market?
2. What is the demand of the global Medication Management in Oncology market?
3. What is the year over year growth of the global Medication Management in Oncology market?
4. What is the total value of the global Medication Management in Oncology market?
5. Who are the major players in the global Medication Management in Oncology market?
6. What are the growth factors driving the market demand?
btl

Table of Contents

1 Supply Summary
1.1 Medication Management in Oncology Introduction
1.2 World Medication Management in Oncology Market Size & Forecast (2018 & 2022 & 2029)
1.3 World Medication Management in Oncology Total Market by Region (by Headquarter Location)
1.3.1 World Medication Management in Oncology Market Size by Region (2018-2029), (by Headquarter Location)
1.3.2 United States Medication Management in Oncology Market Size (2018-2029)
1.3.3 China Medication Management in Oncology Market Size (2018-2029)
1.3.4 Europe Medication Management in Oncology Market Size (2018-2029)
1.3.5 Japan Medication Management in Oncology Market Size (2018-2029)
1.3.6 South Korea Medication Management in Oncology Market Size (2018-2029)
1.3.7 ASEAN Medication Management in Oncology Market Size (2018-2029)
1.3.8 India Medication Management in Oncology Market Size (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Medication Management in Oncology Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Medication Management in Oncology Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War

2 Demand Summary
2.1 World Medication Management in Oncology Consumption Value (2018-2029)
2.2 World Medication Management in Oncology Consumption Value by Region
2.2.1 World Medication Management in Oncology Consumption Value by Region (2018-2023)
2.2.2 World Medication Management in Oncology Consumption Value Forecast by Region (2024-2029)
2.3 United States Medication Management in Oncology Consumption Value (2018-2029)
2.4 China Medication Management in Oncology Consumption Value (2018-2029)
2.5 Europe Medication Management in Oncology Consumption Value (2018-2029)
2.6 Japan Medication Management in Oncology Consumption Value (2018-2029)
2.7 South Korea Medication Management in Oncology Consumption Value (2018-2029)
2.8 ASEAN Medication Management in Oncology Consumption Value (2018-2029)
2.9 India Medication Management in Oncology Consumption Value (2018-2029)

3 World Medication Management in Oncology Companies Competitive Analysis
3.1 World Medication Management in Oncology Revenue by Player (2018-2023)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Medication Management in Oncology Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Medication Management in Oncology in 2022
3.2.3 Global Concentration Ratios (CR8) for Medication Management in Oncology in 2022
3.3 Medication Management in Oncology Company Evaluation Quadrant
3.4 Medication Management in Oncology Market: Overall Company Footprint Analysis
3.4.1 Medication Management in Oncology Market: Region Footprint
3.4.2 Medication Management in Oncology Market: Company Product Type Footprint
3.4.3 Medication Management in Oncology Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers, Acquisitions Activity

4 United States VS China VS Rest of the World (by Headquarter Location)
4.1 United States VS China: Medication Management in Oncology Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Medication Management in Oncology Market Size Comparison (2018 & 2022 & 2029) (by Headquarter Location)
4.1.2 United States VS China: Medication Management in Oncology Revenue Market Share Comparison (2018 & 2022 & 2029)
4.2 United States Based Companies VS China Based Companies: Medication Management in Oncology Consumption Value Comparison
4.2.1 United States VS China: Medication Management in Oncology Consumption Value Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Medication Management in Oncology Consumption Value Market Share Comparison (2018 & 2022 & 2029)
4.3 United States Based Medication Management in Oncology Companies and Market Share, 2018-2023
4.3.1 United States Based Medication Management in Oncology Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Medication Management in Oncology Revenue, (2018-2023)
4.4 China Based Companies Medication Management in Oncology Revenue and Market Share, 2018-2023
4.4.1 China Based Medication Management in Oncology Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Medication Management in Oncology Revenue, (2018-2023)
4.5 Rest of World Based Medication Management in Oncology Companies and Market Share, 2018-2023
4.5.1 Rest of World Based Medication Management in Oncology Companies, Headquarters (States, Country)
4.5.2 Rest of World Based Companies Medication Management in Oncology Revenue, (2018-2023)

5 Market Analysis by Type
5.1 World Medication Management in Oncology Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Oral
5.2.2 Injection
5.2.3 Smear
5.3 Market Segment by Type
5.3.1 World Medication Management in Oncology Market Size by Type (2018-2023)
5.3.2 World Medication Management in Oncology Market Size by Type (2024-2029)
5.3.3 World Medication Management in Oncology Market Size Market Share by Type (2018-2029)

6 Market Analysis by Application
6.1 World Medication Management in Oncology Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Hospital
6.2.2 Clinic
6.2.3 Others
6.3 Market Segment by Application
6.3.1 World Medication Management in Oncology Market Size by Application (2018-2023)
6.3.2 World Medication Management in Oncology Market Size by Application (2024-2029)
6.3.3 World Medication Management in Oncology Market Size by Application (2018-2029)

7 Company Profiles
7.1 B. Braun Melsungen AG
7.1.1 B. Braun Melsungen AG Details
7.1.2 B. Braun Melsungen AG Major Business
7.1.3 B. Braun Melsungen AG Medication Management in Oncology Product and Services
7.1.4 B. Braun Melsungen AG Medication Management in Oncology Revenue, Gross Margin and Market Share (2018-2023)
7.1.5 B. Braun Melsungen AG Recent Developments/Updates
7.1.6 B. Braun Melsungen AG Competitive Strengths & Weaknesses
7.2 Dana-Farber Cancer Institute
7.2.1 Dana-Farber Cancer Institute Details
7.2.2 Dana-Farber Cancer Institute Major Business
7.2.3 Dana-Farber Cancer Institute Medication Management in Oncology Product and Services
7.2.4 Dana-Farber Cancer Institute Medication Management in Oncology Revenue, Gross Margin and Market Share (2018-2023)
7.2.5 Dana-Farber Cancer Institute Recent Developments/Updates
7.2.6 Dana-Farber Cancer Institute Competitive Strengths & Weaknesses
7.3 MedicoRx
7.3.1 MedicoRx Details
7.3.2 MedicoRx Major Business
7.3.3 MedicoRx Medication Management in Oncology Product and Services
7.3.4 MedicoRx Medication Management in Oncology Revenue, Gross Margin and Market Share (2018-2023)
7.3.5 MedicoRx Recent Developments/Updates
7.3.6 MedicoRx Competitive Strengths & Weaknesses
7.4 McKesson Corporation
7.4.1 McKesson Corporation Details
7.4.2 McKesson Corporation Major Business
7.4.3 McKesson Corporation Medication Management in Oncology Product and Services
7.4.4 McKesson Corporation Medication Management in Oncology Revenue, Gross Margin and Market Share (2018-2023)
7.4.5 McKesson Corporation Recent Developments/Updates
7.4.6 McKesson Corporation Competitive Strengths & Weaknesses
7.5 Kroger Specialty Pharmacy
7.5.1 Kroger Specialty Pharmacy Details
7.5.2 Kroger Specialty Pharmacy Major Business
7.5.3 Kroger Specialty Pharmacy Medication Management in Oncology Product and Services
7.5.4 Kroger Specialty Pharmacy Medication Management in Oncology Revenue, Gross Margin and Market Share (2018-2023)
7.5.5 Kroger Specialty Pharmacy Recent Developments/Updates
7.5.6 Kroger Specialty Pharmacy Competitive Strengths & Weaknesses

8 Industry Chain Analysis
8.1 Medication Management in Oncology Industry Chain
8.2 Medication Management in Oncology Upstream Analysis
8.3 Medication Management in Oncology Midstream Analysis
8.4 Medication Management in Oncology Downstream Analysis

9 Research Findings and Conclusion

10 Appendix
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
btl

Table of Figures

List of Tables
Table 1. World Medication Management in Oncology Revenue by Region (2018, 2022 and 2029) & (USD Million), (by Headquarter Location)
Table 2. World Medication Management in Oncology Revenue by Region (2018-2023) & (USD Million), (by Headquarter Location)
Table 3. World Medication Management in Oncology Revenue by Region (2024-2029) & (USD Million), (by Headquarter Location)
Table 4. World Medication Management in Oncology Revenue Market Share by Region (2018-2023), (by Headquarter Location)
Table 5. World Medication Management in Oncology Revenue Market Share by Region (2024-2029), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Medication Management in Oncology Consumption Value Growth Rate Forecast by Region (2018 & 2022 & 2029) & (USD Million)
Table 8. World Medication Management in Oncology Consumption Value by Region (2018-2023) & (USD Million)
Table 9. World Medication Management in Oncology Consumption Value Forecast by Region (2024-2029) & (USD Million)
Table 10. World Medication Management in Oncology Revenue by Player (2018-2023) & (USD Million)
Table 11. Revenue Market Share of Key Medication Management in Oncology Players in 2022
Table 12. World Medication Management in Oncology Industry Rank of Major Player, Based on Revenue in 2022
Table 13. Global Medication Management in Oncology Company Evaluation Quadrant
Table 14. Head Office of Key Medication Management in Oncology Player
Table 15. Medication Management in Oncology Market: Company Product Type Footprint
Table 16. Medication Management in Oncology Market: Company Product Application Footprint
Table 17. Medication Management in Oncology Mergers & Acquisitions Activity
Table 18. United States VS China Medication Management in Oncology Market Size Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 19. United States VS China Medication Management in Oncology Consumption Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 20. United States Based Medication Management in Oncology Companies, Headquarters (States, Country)
Table 21. United States Based Companies Medication Management in Oncology Revenue, (2018-2023) & (USD Million)
Table 22. United States Based Companies Medication Management in Oncology Revenue Market Share (2018-2023)
Table 23. China Based Medication Management in Oncology Companies, Headquarters (Province, Country)
Table 24. China Based Companies Medication Management in Oncology Revenue, (2018-2023) & (USD Million)
Table 25. China Based Companies Medication Management in Oncology Revenue Market Share (2018-2023)
Table 26. Rest of World Based Medication Management in Oncology Companies, Headquarters (States, Country)
Table 27. Rest of World Based Companies Medication Management in Oncology Revenue, (2018-2023) & (USD Million)
Table 28. Rest of World Based Companies Medication Management in Oncology Revenue Market Share (2018-2023)
Table 29. World Medication Management in Oncology Market Size by Type, (USD Million), 2018 & 2022 & 2029
Table 30. World Medication Management in Oncology Market Size by Type (2018-2023) & (USD Million)
Table 31. World Medication Management in Oncology Market Size by Type (2024-2029) & (USD Million)
Table 32. World Medication Management in Oncology Market Size by Application, (USD Million), 2018 & 2022 & 2029
Table 33. World Medication Management in Oncology Market Size by Application (2018-2023) & (USD Million)
Table 34. World Medication Management in Oncology Market Size by Application (2024-2029) & (USD Million)
Table 35. B. Braun Melsungen AG Basic Information, Area Served and Competitors
Table 36. B. Braun Melsungen AG Major Business
Table 37. B. Braun Melsungen AG Medication Management in Oncology Product and Services
Table 38. B. Braun Melsungen AG Medication Management in Oncology Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 39. B. Braun Melsungen AG Recent Developments/Updates
Table 40. B. Braun Melsungen AG Competitive Strengths & Weaknesses
Table 41. Dana-Farber Cancer Institute Basic Information, Area Served and Competitors
Table 42. Dana-Farber Cancer Institute Major Business
Table 43. Dana-Farber Cancer Institute Medication Management in Oncology Product and Services
Table 44. Dana-Farber Cancer Institute Medication Management in Oncology Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 45. Dana-Farber Cancer Institute Recent Developments/Updates
Table 46. Dana-Farber Cancer Institute Competitive Strengths & Weaknesses
Table 47. MedicoRx Basic Information, Area Served and Competitors
Table 48. MedicoRx Major Business
Table 49. MedicoRx Medication Management in Oncology Product and Services
Table 50. MedicoRx Medication Management in Oncology Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 51. MedicoRx Recent Developments/Updates
Table 52. MedicoRx Competitive Strengths & Weaknesses
Table 53. McKesson Corporation Basic Information, Area Served and Competitors
Table 54. McKesson Corporation Major Business
Table 55. McKesson Corporation Medication Management in Oncology Product and Services
Table 56. McKesson Corporation Medication Management in Oncology Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 57. McKesson Corporation Recent Developments/Updates
Table 58. Kroger Specialty Pharmacy Basic Information, Area Served and Competitors
Table 59. Kroger Specialty Pharmacy Major Business
Table 60. Kroger Specialty Pharmacy Medication Management in Oncology Product and Services
Table 61. Kroger Specialty Pharmacy Medication Management in Oncology Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 62. Global Key Players of Medication Management in Oncology Upstream (Raw Materials)
Table 63. Medication Management in Oncology Typical Customers
List of Figure
Figure 1. Medication Management in Oncology Picture
Figure 2. World Medication Management in Oncology Total Market Size: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Medication Management in Oncology Total Market Size (2018-2029) & (USD Million)
Figure 4. World Medication Management in Oncology Revenue Market Share by Region (2018, 2022 and 2029) & (USD Million) , (by Headquarter Location)
Figure 5. World Medication Management in Oncology Revenue Market Share by Region (2018-2029), (by Headquarter Location)
Figure 6. United States Based Company Medication Management in Oncology Revenue (2018-2029) & (USD Million)
Figure 7. China Based Company Medication Management in Oncology Revenue (2018-2029) & (USD Million)
Figure 8. Europe Based Company Medication Management in Oncology Revenue (2018-2029) & (USD Million)
Figure 9. Japan Based Company Medication Management in Oncology Revenue (2018-2029) & (USD Million)
Figure 10. South Korea Based Company Medication Management in Oncology Revenue (2018-2029) & (USD Million)
Figure 11. ASEAN Based Company Medication Management in Oncology Revenue (2018-2029) & (USD Million)
Figure 12. India Based Company Medication Management in Oncology Revenue (2018-2029) & (USD Million)
Figure 13. Medication Management in Oncology Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Medication Management in Oncology Consumption Value (2018-2029) & (USD Million)
Figure 16. World Medication Management in Oncology Consumption Value Market Share by Region (2018-2029)
Figure 17. United States Medication Management in Oncology Consumption Value (2018-2029) & (USD Million)
Figure 18. China Medication Management in Oncology Consumption Value (2018-2029) & (USD Million)
Figure 19. Europe Medication Management in Oncology Consumption Value (2018-2029) & (USD Million)
Figure 20. Japan Medication Management in Oncology Consumption Value (2018-2029) & (USD Million)
Figure 21. South Korea Medication Management in Oncology Consumption Value (2018-2029) & (USD Million)
Figure 22. ASEAN Medication Management in Oncology Consumption Value (2018-2029) & (USD Million)
Figure 23. India Medication Management in Oncology Consumption Value (2018-2029) & (USD Million)
Figure 24. Producer Shipments of Medication Management in Oncology by Player Revenue ($MM) and Market Share (%): 2022
Figure 25. Global Four-firm Concentration Ratios (CR4) for Medication Management in Oncology Markets in 2022
Figure 26. Global Four-firm Concentration Ratios (CR8) for Medication Management in Oncology Markets in 2022
Figure 27. United States VS China: Medication Management in Oncology Revenue Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Medication Management in Oncology Consumption Value Market Share Comparison (2018 & 2022 & 2029)
Figure 29. World Medication Management in Oncology Market Size by Type, (USD Million), 2018 & 2022 & 2029
Figure 30. World Medication Management in Oncology Market Size Market Share by Type in 2022
Figure 31. Oral
Figure 32. Injection
Figure 33. Smear
Figure 34. World Medication Management in Oncology Market Size Market Share by Type (2018-2029)
Figure 35. World Medication Management in Oncology Market Size by Application, (USD Million), 2018 & 2022 & 2029
Figure 36. World Medication Management in Oncology Market Size Market Share by Application in 2022
Figure 37. Hospital
Figure 38. Clinic
Figure 39. Others
Figure 40. Medication Management in Oncology Industrial Chain
Figure 41. Methodology
Figure 42. Research Process and Data Source
btl

Research Methodology

Client Requirements

yuan2

Review and analyze client requirements

yuan2

Discussion of all the project requirements and queries

Flexibility Check

yuan2

Project Feasibility Analysis

yuan2

Finalizing tentative research programme

yuan2

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

yuan2

Determination of key drivers, restraints, challenge, and opportunity

yuan2

Identifies market needs and trends

Market Size Estimation & Forecast

yuan2

Estimation of historical data based on secondary and primary data

yuan2

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

yuan2

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

yuan2

Consideration of geography, region-specific product/service demand for region segments

yuan2

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

tuBiao1

Data Source

yuan2

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

yuan2

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

yuan2

Collection of data

yuan2

Cumulating and collating the essential qualitative and quantitative data

yuan2

Generation of report in client requested format by research analysts

yuan2

Reviews by expert analysts

yuan2

Final quality check

yuan2

Clarifying queries

yuan2

Receiving feedback

yuan2

Ensuring satisfaction

  • yuan01
    liuCheng01

    01 Identification of data

    This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.

  • yuan01
    liuCheng01

    02 Evaluation of Market Dynamic

    This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.

  • yuan01
    liuCheng01

    03 Collection of Data

    This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.

  • yuan01
    liuCheng01

    04 Collaboration of Data

    This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.

  • yuan01
    liuCheng01

    05 Verification and Analysis

    This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

shop_t

Purchase Options

jiaGou

Add To Cart

jiaGou

Buy Now

masterCard
visa
jcb
americanExpress
shop_b
Global Medication Management in Oncology Supply, Demand and Key Producers, 2023-2029

Global Medication Management in Oncology Supply, Demand and Key Producers, 2023-2029

Page: 95

Published Date: 23 Mar 2023

Category: Medical Care

PDF Download

Get FREE Sample

Customize Request

Description

arrow-d3
btl

Description

The global Medication Management in Oncology market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).

This report studies the global Medication Management in Oncology demand, key companies, and key regions.

This report is a detailed and comprehensive analysis of the world market for Medication Management in Oncology, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Medication Management in Oncology that contribute to its increasing demand across many markets.

Highlights and key features of the study
Global Medication Management in Oncology total market, 2018-2029, (USD Million)
Global Medication Management in Oncology total market by region & country, CAGR, 2018-2029, (USD Million)
U.S. VS China: Medication Management in Oncology total market, key domestic companies and share, (USD Million)
Global Medication Management in Oncology revenue by player and market share 2018-2023, (USD Million)
Global Medication Management in Oncology total market by Type, CAGR, 2018-2029, (USD Million)
Global Medication Management in Oncology total market by Application, CAGR, 2018-2029, (USD Million)
This reports profiles major players in the global Medication Management in Oncology market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include B. Braun Melsungen AG, Dana-Farber Cancer Institute, MedicoRx, McKesson Corporation and Kroger Specialty Pharmacy, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Medication Management in Oncology market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.

Global Medication Management in Oncology Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World

Global Medication Management in Oncology Market, Segmentation by Type
Oral
Injection
Smear

Global Medication Management in Oncology Market, Segmentation by Application
Hospital
Clinic
Others

Companies Profiled:
B. Braun Melsungen AG
Dana-Farber Cancer Institute
MedicoRx
McKesson Corporation
Kroger Specialty Pharmacy

Key Questions Answered
1. How big is the global Medication Management in Oncology market?
2. What is the demand of the global Medication Management in Oncology market?
3. What is the year over year growth of the global Medication Management in Oncology market?
4. What is the total value of the global Medication Management in Oncology market?
5. Who are the major players in the global Medication Management in Oncology market?
6. What are the growth factors driving the market demand?
btl

Table of Contents

1 Supply Summary
1.1 Medication Management in Oncology Introduction
1.2 World Medication Management in Oncology Market Size & Forecast (2018 & 2022 & 2029)
1.3 World Medication Management in Oncology Total Market by Region (by Headquarter Location)
1.3.1 World Medication Management in Oncology Market Size by Region (2018-2029), (by Headquarter Location)
1.3.2 United States Medication Management in Oncology Market Size (2018-2029)
1.3.3 China Medication Management in Oncology Market Size (2018-2029)
1.3.4 Europe Medication Management in Oncology Market Size (2018-2029)
1.3.5 Japan Medication Management in Oncology Market Size (2018-2029)
1.3.6 South Korea Medication Management in Oncology Market Size (2018-2029)
1.3.7 ASEAN Medication Management in Oncology Market Size (2018-2029)
1.3.8 India Medication Management in Oncology Market Size (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Medication Management in Oncology Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Medication Management in Oncology Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War

2 Demand Summary
2.1 World Medication Management in Oncology Consumption Value (2018-2029)
2.2 World Medication Management in Oncology Consumption Value by Region
2.2.1 World Medication Management in Oncology Consumption Value by Region (2018-2023)
2.2.2 World Medication Management in Oncology Consumption Value Forecast by Region (2024-2029)
2.3 United States Medication Management in Oncology Consumption Value (2018-2029)
2.4 China Medication Management in Oncology Consumption Value (2018-2029)
2.5 Europe Medication Management in Oncology Consumption Value (2018-2029)
2.6 Japan Medication Management in Oncology Consumption Value (2018-2029)
2.7 South Korea Medication Management in Oncology Consumption Value (2018-2029)
2.8 ASEAN Medication Management in Oncology Consumption Value (2018-2029)
2.9 India Medication Management in Oncology Consumption Value (2018-2029)

3 World Medication Management in Oncology Companies Competitive Analysis
3.1 World Medication Management in Oncology Revenue by Player (2018-2023)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Medication Management in Oncology Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Medication Management in Oncology in 2022
3.2.3 Global Concentration Ratios (CR8) for Medication Management in Oncology in 2022
3.3 Medication Management in Oncology Company Evaluation Quadrant
3.4 Medication Management in Oncology Market: Overall Company Footprint Analysis
3.4.1 Medication Management in Oncology Market: Region Footprint
3.4.2 Medication Management in Oncology Market: Company Product Type Footprint
3.4.3 Medication Management in Oncology Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers, Acquisitions Activity

4 United States VS China VS Rest of the World (by Headquarter Location)
4.1 United States VS China: Medication Management in Oncology Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Medication Management in Oncology Market Size Comparison (2018 & 2022 & 2029) (by Headquarter Location)
4.1.2 United States VS China: Medication Management in Oncology Revenue Market Share Comparison (2018 & 2022 & 2029)
4.2 United States Based Companies VS China Based Companies: Medication Management in Oncology Consumption Value Comparison
4.2.1 United States VS China: Medication Management in Oncology Consumption Value Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Medication Management in Oncology Consumption Value Market Share Comparison (2018 & 2022 & 2029)
4.3 United States Based Medication Management in Oncology Companies and Market Share, 2018-2023
4.3.1 United States Based Medication Management in Oncology Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Medication Management in Oncology Revenue, (2018-2023)
4.4 China Based Companies Medication Management in Oncology Revenue and Market Share, 2018-2023
4.4.1 China Based Medication Management in Oncology Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Medication Management in Oncology Revenue, (2018-2023)
4.5 Rest of World Based Medication Management in Oncology Companies and Market Share, 2018-2023
4.5.1 Rest of World Based Medication Management in Oncology Companies, Headquarters (States, Country)
4.5.2 Rest of World Based Companies Medication Management in Oncology Revenue, (2018-2023)

5 Market Analysis by Type
5.1 World Medication Management in Oncology Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Oral
5.2.2 Injection
5.2.3 Smear
5.3 Market Segment by Type
5.3.1 World Medication Management in Oncology Market Size by Type (2018-2023)
5.3.2 World Medication Management in Oncology Market Size by Type (2024-2029)
5.3.3 World Medication Management in Oncology Market Size Market Share by Type (2018-2029)

6 Market Analysis by Application
6.1 World Medication Management in Oncology Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Hospital
6.2.2 Clinic
6.2.3 Others
6.3 Market Segment by Application
6.3.1 World Medication Management in Oncology Market Size by Application (2018-2023)
6.3.2 World Medication Management in Oncology Market Size by Application (2024-2029)
6.3.3 World Medication Management in Oncology Market Size by Application (2018-2029)

7 Company Profiles
7.1 B. Braun Melsungen AG
7.1.1 B. Braun Melsungen AG Details
7.1.2 B. Braun Melsungen AG Major Business
7.1.3 B. Braun Melsungen AG Medication Management in Oncology Product and Services
7.1.4 B. Braun Melsungen AG Medication Management in Oncology Revenue, Gross Margin and Market Share (2018-2023)
7.1.5 B. Braun Melsungen AG Recent Developments/Updates
7.1.6 B. Braun Melsungen AG Competitive Strengths & Weaknesses
7.2 Dana-Farber Cancer Institute
7.2.1 Dana-Farber Cancer Institute Details
7.2.2 Dana-Farber Cancer Institute Major Business
7.2.3 Dana-Farber Cancer Institute Medication Management in Oncology Product and Services
7.2.4 Dana-Farber Cancer Institute Medication Management in Oncology Revenue, Gross Margin and Market Share (2018-2023)
7.2.5 Dana-Farber Cancer Institute Recent Developments/Updates
7.2.6 Dana-Farber Cancer Institute Competitive Strengths & Weaknesses
7.3 MedicoRx
7.3.1 MedicoRx Details
7.3.2 MedicoRx Major Business
7.3.3 MedicoRx Medication Management in Oncology Product and Services
7.3.4 MedicoRx Medication Management in Oncology Revenue, Gross Margin and Market Share (2018-2023)
7.3.5 MedicoRx Recent Developments/Updates
7.3.6 MedicoRx Competitive Strengths & Weaknesses
7.4 McKesson Corporation
7.4.1 McKesson Corporation Details
7.4.2 McKesson Corporation Major Business
7.4.3 McKesson Corporation Medication Management in Oncology Product and Services
7.4.4 McKesson Corporation Medication Management in Oncology Revenue, Gross Margin and Market Share (2018-2023)
7.4.5 McKesson Corporation Recent Developments/Updates
7.4.6 McKesson Corporation Competitive Strengths & Weaknesses
7.5 Kroger Specialty Pharmacy
7.5.1 Kroger Specialty Pharmacy Details
7.5.2 Kroger Specialty Pharmacy Major Business
7.5.3 Kroger Specialty Pharmacy Medication Management in Oncology Product and Services
7.5.4 Kroger Specialty Pharmacy Medication Management in Oncology Revenue, Gross Margin and Market Share (2018-2023)
7.5.5 Kroger Specialty Pharmacy Recent Developments/Updates
7.5.6 Kroger Specialty Pharmacy Competitive Strengths & Weaknesses

8 Industry Chain Analysis
8.1 Medication Management in Oncology Industry Chain
8.2 Medication Management in Oncology Upstream Analysis
8.3 Medication Management in Oncology Midstream Analysis
8.4 Medication Management in Oncology Downstream Analysis

9 Research Findings and Conclusion

10 Appendix
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
btl

Table of Figures

List of Tables
Table 1. World Medication Management in Oncology Revenue by Region (2018, 2022 and 2029) & (USD Million), (by Headquarter Location)
Table 2. World Medication Management in Oncology Revenue by Region (2018-2023) & (USD Million), (by Headquarter Location)
Table 3. World Medication Management in Oncology Revenue by Region (2024-2029) & (USD Million), (by Headquarter Location)
Table 4. World Medication Management in Oncology Revenue Market Share by Region (2018-2023), (by Headquarter Location)
Table 5. World Medication Management in Oncology Revenue Market Share by Region (2024-2029), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Medication Management in Oncology Consumption Value Growth Rate Forecast by Region (2018 & 2022 & 2029) & (USD Million)
Table 8. World Medication Management in Oncology Consumption Value by Region (2018-2023) & (USD Million)
Table 9. World Medication Management in Oncology Consumption Value Forecast by Region (2024-2029) & (USD Million)
Table 10. World Medication Management in Oncology Revenue by Player (2018-2023) & (USD Million)
Table 11. Revenue Market Share of Key Medication Management in Oncology Players in 2022
Table 12. World Medication Management in Oncology Industry Rank of Major Player, Based on Revenue in 2022
Table 13. Global Medication Management in Oncology Company Evaluation Quadrant
Table 14. Head Office of Key Medication Management in Oncology Player
Table 15. Medication Management in Oncology Market: Company Product Type Footprint
Table 16. Medication Management in Oncology Market: Company Product Application Footprint
Table 17. Medication Management in Oncology Mergers & Acquisitions Activity
Table 18. United States VS China Medication Management in Oncology Market Size Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 19. United States VS China Medication Management in Oncology Consumption Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 20. United States Based Medication Management in Oncology Companies, Headquarters (States, Country)
Table 21. United States Based Companies Medication Management in Oncology Revenue, (2018-2023) & (USD Million)
Table 22. United States Based Companies Medication Management in Oncology Revenue Market Share (2018-2023)
Table 23. China Based Medication Management in Oncology Companies, Headquarters (Province, Country)
Table 24. China Based Companies Medication Management in Oncology Revenue, (2018-2023) & (USD Million)
Table 25. China Based Companies Medication Management in Oncology Revenue Market Share (2018-2023)
Table 26. Rest of World Based Medication Management in Oncology Companies, Headquarters (States, Country)
Table 27. Rest of World Based Companies Medication Management in Oncology Revenue, (2018-2023) & (USD Million)
Table 28. Rest of World Based Companies Medication Management in Oncology Revenue Market Share (2018-2023)
Table 29. World Medication Management in Oncology Market Size by Type, (USD Million), 2018 & 2022 & 2029
Table 30. World Medication Management in Oncology Market Size by Type (2018-2023) & (USD Million)
Table 31. World Medication Management in Oncology Market Size by Type (2024-2029) & (USD Million)
Table 32. World Medication Management in Oncology Market Size by Application, (USD Million), 2018 & 2022 & 2029
Table 33. World Medication Management in Oncology Market Size by Application (2018-2023) & (USD Million)
Table 34. World Medication Management in Oncology Market Size by Application (2024-2029) & (USD Million)
Table 35. B. Braun Melsungen AG Basic Information, Area Served and Competitors
Table 36. B. Braun Melsungen AG Major Business
Table 37. B. Braun Melsungen AG Medication Management in Oncology Product and Services
Table 38. B. Braun Melsungen AG Medication Management in Oncology Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 39. B. Braun Melsungen AG Recent Developments/Updates
Table 40. B. Braun Melsungen AG Competitive Strengths & Weaknesses
Table 41. Dana-Farber Cancer Institute Basic Information, Area Served and Competitors
Table 42. Dana-Farber Cancer Institute Major Business
Table 43. Dana-Farber Cancer Institute Medication Management in Oncology Product and Services
Table 44. Dana-Farber Cancer Institute Medication Management in Oncology Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 45. Dana-Farber Cancer Institute Recent Developments/Updates
Table 46. Dana-Farber Cancer Institute Competitive Strengths & Weaknesses
Table 47. MedicoRx Basic Information, Area Served and Competitors
Table 48. MedicoRx Major Business
Table 49. MedicoRx Medication Management in Oncology Product and Services
Table 50. MedicoRx Medication Management in Oncology Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 51. MedicoRx Recent Developments/Updates
Table 52. MedicoRx Competitive Strengths & Weaknesses
Table 53. McKesson Corporation Basic Information, Area Served and Competitors
Table 54. McKesson Corporation Major Business
Table 55. McKesson Corporation Medication Management in Oncology Product and Services
Table 56. McKesson Corporation Medication Management in Oncology Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 57. McKesson Corporation Recent Developments/Updates
Table 58. Kroger Specialty Pharmacy Basic Information, Area Served and Competitors
Table 59. Kroger Specialty Pharmacy Major Business
Table 60. Kroger Specialty Pharmacy Medication Management in Oncology Product and Services
Table 61. Kroger Specialty Pharmacy Medication Management in Oncology Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 62. Global Key Players of Medication Management in Oncology Upstream (Raw Materials)
Table 63. Medication Management in Oncology Typical Customers
List of Figure
Figure 1. Medication Management in Oncology Picture
Figure 2. World Medication Management in Oncology Total Market Size: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Medication Management in Oncology Total Market Size (2018-2029) & (USD Million)
Figure 4. World Medication Management in Oncology Revenue Market Share by Region (2018, 2022 and 2029) & (USD Million) , (by Headquarter Location)
Figure 5. World Medication Management in Oncology Revenue Market Share by Region (2018-2029), (by Headquarter Location)
Figure 6. United States Based Company Medication Management in Oncology Revenue (2018-2029) & (USD Million)
Figure 7. China Based Company Medication Management in Oncology Revenue (2018-2029) & (USD Million)
Figure 8. Europe Based Company Medication Management in Oncology Revenue (2018-2029) & (USD Million)
Figure 9. Japan Based Company Medication Management in Oncology Revenue (2018-2029) & (USD Million)
Figure 10. South Korea Based Company Medication Management in Oncology Revenue (2018-2029) & (USD Million)
Figure 11. ASEAN Based Company Medication Management in Oncology Revenue (2018-2029) & (USD Million)
Figure 12. India Based Company Medication Management in Oncology Revenue (2018-2029) & (USD Million)
Figure 13. Medication Management in Oncology Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Medication Management in Oncology Consumption Value (2018-2029) & (USD Million)
Figure 16. World Medication Management in Oncology Consumption Value Market Share by Region (2018-2029)
Figure 17. United States Medication Management in Oncology Consumption Value (2018-2029) & (USD Million)
Figure 18. China Medication Management in Oncology Consumption Value (2018-2029) & (USD Million)
Figure 19. Europe Medication Management in Oncology Consumption Value (2018-2029) & (USD Million)
Figure 20. Japan Medication Management in Oncology Consumption Value (2018-2029) & (USD Million)
Figure 21. South Korea Medication Management in Oncology Consumption Value (2018-2029) & (USD Million)
Figure 22. ASEAN Medication Management in Oncology Consumption Value (2018-2029) & (USD Million)
Figure 23. India Medication Management in Oncology Consumption Value (2018-2029) & (USD Million)
Figure 24. Producer Shipments of Medication Management in Oncology by Player Revenue ($MM) and Market Share (%): 2022
Figure 25. Global Four-firm Concentration Ratios (CR4) for Medication Management in Oncology Markets in 2022
Figure 26. Global Four-firm Concentration Ratios (CR8) for Medication Management in Oncology Markets in 2022
Figure 27. United States VS China: Medication Management in Oncology Revenue Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Medication Management in Oncology Consumption Value Market Share Comparison (2018 & 2022 & 2029)
Figure 29. World Medication Management in Oncology Market Size by Type, (USD Million), 2018 & 2022 & 2029
Figure 30. World Medication Management in Oncology Market Size Market Share by Type in 2022
Figure 31. Oral
Figure 32. Injection
Figure 33. Smear
Figure 34. World Medication Management in Oncology Market Size Market Share by Type (2018-2029)
Figure 35. World Medication Management in Oncology Market Size by Application, (USD Million), 2018 & 2022 & 2029
Figure 36. World Medication Management in Oncology Market Size Market Share by Application in 2022
Figure 37. Hospital
Figure 38. Clinic
Figure 39. Others
Figure 40. Medication Management in Oncology Industrial Chain
Figure 41. Methodology
Figure 42. Research Process and Data Source
btl

Research Methodology

Client Requirements

yuan2

Review and analyze client requirements

yuan2

Discussion of all the project requirements and queries

Flexibility Check

yuan2

Project Feasibility Analysis

yuan2

Finalizing tentative research programme

yuan2

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

yuan2

Determination of key drivers, restraints, challenge, and opportunity

yuan2

Identifies market needs and trends

Market Size Estimation & Forecast

yuan2

Estimation of historical data based on secondary and primary data

yuan2

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

yuan2

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

yuan2

Consideration of geography, region-specific product/service demand for region segments

yuan2

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

tuBiao1

Data Source

yuan2

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

yuan2

Discussion of all the project requirements and queries

Validation and triangulation of secondary and primary source.

yuan2

Collection of data

yuan2

Cumulating and collating the essential qualitative and quantitative data

yuan2

Generation of report in client requested format by research analysts

yuan2

Reviews by expert analysts

yuan2

Final quality check

yuan2

Clarifying queries

yuan2

Receiving feedback

yuan2

Ensuring satisfaction

  • yuan01
    liuCheng01

    01 Identification of data

    This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.

  • yuan01
    liuCheng01

    02 Evaluation of Market Dynamic

    This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.

  • yuan01
    liuCheng01

    03 Collection of Data

    This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.

  • yuan01
    liuCheng01

    04 Collaboration of Data

    This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.

  • yuan01
    liuCheng01

    05 Verification and Analysis

    This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

jiaGou

Add To Cart

gouMai

Buy Now